# Alto Ingredients share price today (Alto Ingredients, Inc., ALTO) > Alto Ingredients, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. ALTO · Materials · Specialty Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/alto Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Price: $3.55 (+251.5% in a year) - P/E: 5.4× (lower than 96% of the last 10 months) - Revenue (Jun 2026): $246 M (+12.5% on a year ago) - Profit (Jun 2026): $11.4 M - Operating margin: 3.5% (+7.6 points on a year ago) - ROE: 5%, FY25 - ROIC: 11.5%, against a 6.0% cost of capital: +5.5 points - Profit that came in as cash: 71%, last 2 years Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Alto Ingredients share price today? Alto Ingredients, Inc.'s share price was $3.55 at the close on 3 November 2026. That is 17.2% below its average price over the last 200 trading days. In the last 52 weeks it traded between $1 and $6, and at that close it sat 49% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 16 weeks running. Over the last 1 year the share price moved +186% while the S&P 500 moved +21%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 17 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Alto Ingredients pay? Alto Ingredients, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Alto Ingredients on? Alto Ingredients is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Alto Ingredients profitable? Alto Ingredients, Inc. earned $11.4 M of net profit in the Jun 2026 quarter. Full-year FY25 profit was $12.1 M. Over 4 years profit has grown −27.7% a year on average. That is 4.6% of the quarter's revenue. The same quarter a year earlier lost $11.3 M. 8 of the last 12 reported quarters were loss-making. ## How much revenue does Alto Ingredients make, and is it growing? Alto Ingredients, Inc. reported $246 M of revenue in the Jun 2026 quarter, +12.5% on the same quarter a year earlier. Over 4 years it has grown −6.6% a year on average. The last full year, FY25, came in at $918 M. The last four reported quarters add to $943 M. FY25 revenue was $918 M, −4.9% on the year before. Recent pace: the last four quarters grew +1.4% on average, against −6.6% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +1.1%, against −6.1% a year over the last 8 quarters (accelerating). ## How much of every $100 of sales does Alto Ingredients keep? Alto Ingredients, Inc.'s operating margin was 3.5% in the Jun 2026 quarter, 7.6 percentage points higher than the same quarter a year ago. Across 5 years it has been between −4.2% and 3.2%. The latest quarter is above every full year in that period. Why the margin moved: operating margin changed +7.6 percentage points on the year while gross margin changed +7.7 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Alto Ingredients' profit turning into cash? Over the last 2 years, 71% of Alto Ingredients, Inc.'s reported profit came in as cash from its operations, so most of the profit is real cash. In FY25 it brought in $13.2 M of operating cash against $12.1 M of profit. After $4.6 M of spending on assets, $8.6 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Alto Ingredients' cash go? Alto Ingredients, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $45.2 M on assets over the last 3 years. Averaged over those years that is 1.6% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $45.2 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Alto Ingredients' P/E ratio, and how does it compare with its own history? Alto Ingredients, Inc.'s P/E is 5.4×, near the low end of its own history: it has been lower only 4% of the time. Its usual P/E (the middle reading) is 12.9×, over 10 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Alto Ingredients business getting better or worse? Alto Ingredients, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Alto Ingredients earn on its capital? Alto Ingredients, Inc. earned a ROE of 5% in FY25. That is up from a low of −27% in FY24. Its return on capital used (ROIC) is 5.5 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 1.3% net margin and 2.36× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 1.3% net margin × 2.36× asset turnover × 1.59× leverage (assets divided by equity) ≈ 4.9% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 11.5% − 6.0% = +5.5 percentage points. The 6.0% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. The 11.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 2.5%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Alto Ingredients have too much debt? Alto Ingredients, Inc. has total debt of $82.9 M against shareholder equity of $260 M as of Jun 2026, so its debt is 0.32× its equity. Year by year, that ratio went from 0.18 in FY21 to 0.40 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Alto Ingredients shareholding pattern? 8.1% of Alto Ingredients, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 5.2 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Alto Ingredients from balance-sheet trouble? For Alto Ingredients, Inc., the Z-score is 1.15. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 1.15 is inside the danger zone, so the balance sheet is a real risk. ## How does Alto Ingredients rank in its industry? There is no score against its industry: Alto Ingredients, Inc. is not among the largest members shown in this industry comparison for Specialty Chemicals. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Alto Ingredients compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Alto Ingredients in size? Alto Ingredients is the 44th largest of 47 Specialty Chemicals companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Montauk Renewables, Inc., Orion S.A. and Gevo, Inc. Just below it: FutureFuel Corp., Hudson Technologies, Inc. and Core Molding Technologies, Inc. ### Specialty Chemicals companies close in size 1. [Montauk Renewables, Inc.](https://www.sectoralpha.in/us/stocks/mntk) $355 million 2. [Orion S.A.](https://www.sectoralpha.in/us/stocks/oec) $311 million 3. [Gevo, Inc.](https://www.sectoralpha.in/us/stocks/gevo) $285 million 4. Alto Ingredients, Inc. $275 million 5. [FutureFuel Corp.](https://www.sectoralpha.in/us/stocks/ff) $250 million 6. [Hudson Technologies, Inc.](https://www.sectoralpha.in/us/stocks/hdsn) $182 million 7. [Core Molding Technologies, Inc.](https://www.sectoralpha.in/us/stocks/cmt) $178 million [All 47 Specialty Chemicals companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-chemicals#all-companies) ### Companies close in size in other industries 1. [Kingsway Corporation](https://www.sectoralpha.in/us/stocks/kwy) $284 million · Asset Management 2. [Asure Software, Inc.](https://www.sectoralpha.in/us/stocks/asur) $284 million · Software - Application 3. Alto Ingredients, Inc. $283 million 4. [Fulcrum Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/fulc) $283 million · Biotechnology 5. [Inhibikase Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/ikt) $282 million · Biotechnology ## What else do people ask about Alto Ingredients? ### What were Alto Ingredients's latest quarterly results? Alto Ingredients, Inc. reported revenue of $246 M and net profit of $11.4 M for the Jun 2026 quarter. Earnings per share were $0.15. The operating margin was 3.5%, 7.6 percentage points higher than a year earlier (as of 3 November 2026). ### What is Alto Ingredients's market cap? Alto Ingredients, Inc.'s market capitalisation is $275 M at a stock price of $3.55. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Alto Ingredients performing? Alto Ingredients, Inc.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 16 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Alto Ingredients's stock price go up? This page does not forecast Alto Ingredients, Inc.'s stock price. What it shows instead: the stock price is $3.55. Its P/E of 5.4× is higher than 4% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Alto Ingredients in its business cycle? Alto Ingredients, Inc.'s FY25 operating margin was 0.8%, against a 5-year range of −4.2% to 3.2%: the middle of its own range, neither a peak nor a low. The latest quarter was 3.5%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Alto Ingredients story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Alto Ingredients a stock worth studying right now? What the numbers show: Alto Ingredients, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.